Loss of wild type KRAS in KRAS lung adenocarcinoma is associated with cancer mortality and confers sensitivity to FASN inhibitors
Yan Liu, Galen F. Gao, John D. Minna, Noelle S. Williams, Kenneth D. Westover
Topics & Concepts
KRASFatty acid synthaseAdenocarcinomaMedicineContext (archaeology)Lung cancerCancer researchCancerInternal medicineOncologyBiomarkerBiologyColorectal cancerLipid metabolismGeneticsPaleontologyCancer, Lipids, and MetabolismRNA modifications and cancerFerroptosis and cancer prognosis